BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 1658787)

  • 1. Alternative splicing and genomic structure of the Wilms tumor gene WT1.
    Haber DA; Sohn RL; Buckler AJ; Pelletier J; Call KM; Housman DE
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9618-22. PubMed ID: 1658787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA polymerase chain reaction detects different levels of four alternatively spliced WT1 transcripts in Wilms' tumors.
    Brenner B; Wildhardt G; Schneider S; Royer-Pokora B
    Oncogene; 1992 Jul; 7(7):1431-3. PubMed ID: 1320246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentially spliced exon 5 of the Wilms' tumor gene WT1 modifies gene function.
    Hewitt SM; Saunders GF
    Anticancer Res; 1996; 16(2):621-6. PubMed ID: 8687106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variant.
    Haber DA; Park S; Maheswaran S; Englert C; Re GG; Hazen-Martin DJ; Sens DA; Garvin AJ
    Science; 1993 Dec; 262(5142):2057-9. PubMed ID: 8266105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Did nucleotides or amino acids drive evolutionary conservation of the WT1 +/-KTS alternative splice?
    Davies RC; Bratt E; Hastie ND
    Hum Mol Genet; 2000 May; 9(8):1177-83. PubMed ID: 10767342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression in Xenopus oocytes shows that WT1 binds transcripts in vivo, with a central role for zinc finger one.
    Ladomery M; Sommerville J; Woolner S; Slight J; Hastie N
    J Cell Sci; 2003 Apr; 116(Pt 8):1539-49. PubMed ID: 12640038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wilms' tumor 1 splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby-rat kidney cells.
    Menke AL; Riteco N; van Ham RC; de Bruyne C; Rauscher FJ; van der Eb AJ; Jochemsen AG
    Oncogene; 1996 Feb; 12(3):537-46. PubMed ID: 8637710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor.
    Rauscher FJ
    FASEB J; 1993 Jul; 7(10):896-903. PubMed ID: 8393820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional repression mediated by the WT1 Wilms tumor gene product.
    Madden SL; Cook DM; Morris JF; Gashler A; Sukhatme VP; Rauscher FJ
    Science; 1991 Sep; 253(5027):1550-3. PubMed ID: 1654597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development.
    Buckler AJ; Pelletier J; Haber DA; Glaser T; Housman DE
    Mol Cell Biol; 1991 Mar; 11(3):1707-12. PubMed ID: 1671709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor.
    Haber DA; Buckler AJ; Glaser T; Call KM; Pelletier J; Sohn RL; Douglass EC; Housman DE
    Cell; 1990 Jun; 61(7):1257-69. PubMed ID: 2163761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.
    Park S; Tomlinson G; Nisen P; Haber DA
    Cancer Res; 1993 Oct; 53(20):4757-60. PubMed ID: 8402654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the cellular protein encoded by the human Wilms' tumor (WT1) gene.
    Telerman A; Dodemont H; Degraef C; Galand P; Bauwens S; Van Oostveldt P; Amson RB
    Oncogene; 1992 Dec; 7(12):2545-8. PubMed ID: 1334252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wilms tumor and the WT1 gene.
    Lee SB; Haber DA
    Exp Cell Res; 2001 Mar; 264(1):74-99. PubMed ID: 11237525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of the remaining allele of the WT1 gene in a Wilms' tumour from a WAGR patient.
    Brown KW; Watson JE; Poirier V; Mott MG; Berry PJ; Maitland NJ
    Oncogene; 1992 Apr; 7(4):763-8. PubMed ID: 1314370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
    Scharnhorst V; Menke AL; Attema J; Haneveld JK; Riteco N; van Steenbrugge GJ; van der Eb AJ; Jochemsen AG
    Oncogene; 2000 Feb; 19(6):791-800. PubMed ID: 10698497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of DNA binding specificity by alternative splicing of the Wilms tumor wt1 gene transcript.
    Bickmore WA; Oghene K; Little MH; Seawright A; van Heyningen V; Hastie ND
    Science; 1992 Jul; 257(5067):235-7. PubMed ID: 1321494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA binding by the Wilms tumor suppressor zinc finger proteins.
    Caricasole A; Duarte A; Larsson SH; Hastie ND; Little M; Holmes G; Todorov I; Ward A
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7562-6. PubMed ID: 8755514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homozygous somatic Wt1 point mutations in sporadic unilateral Wilms tumor.
    Coppes MJ; Liefers GJ; Paul P; Yeger H; Williams BR
    Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1416-9. PubMed ID: 8381965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus.
    Morris JF; Madden SL; Tournay OE; Cook DM; Sukhatme VP; Rauscher FJ
    Oncogene; 1991 Dec; 6(12):2339-48. PubMed ID: 1662794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.